Literature DB >> 6130139

Comparative pharmacokinetics of benzodiazepines in dog and man.

H Boxenbaum.   

Abstract

The pharmacokinetic parameters disposition half-life, metabolic clearance, volume of distribution, intrinsic clearance of unbound drug, and (distributive tissue volume/unbound fraction in tissue) were compared for 12 benzodiazepines in dog and man. With the exception of volume of distribution, statistically significant correlations were obtained when parameters were plotted on a double logarithmic grid. In general, benzodiazepines were metabolized more rapidly and exhibited greater tissue distribution in dog than in man. The variability in parameters was such, however, as to make extrapolations from one species to another subject to considerable error.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6130139     DOI: 10.1007/bf01065172

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  41 in total

1.  Biopharmaceutical and clinical pharmacokinetic profile of bromazepam.

Authors:  S A Kaplan; M L Jack; R E Weinfeld; W Glover; L Weissman; S Cotler
Journal:  J Pharmacokinet Biopharm       Date:  1976-02

2.  Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and by repeated oral administration.

Authors:  A Berlin; H Dahlström
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

3.  Influence of phenobarbital on the disposition of clonazepam and antipyrine in the dog.

Authors:  I Bekersky; A C Maggio; V Mattaliano; H G Boxenbaum; D E Maynard; P D Cohn; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

4.  Plasma concentrations of medazepam and its metabolites after oral administration.

Authors:  D M Hailey; E S Baird
Journal:  Br J Anaesth       Date:  1979-06       Impact factor: 9.166

Review 5.  Metabolism of foreign compounds by gastrointestinal microorganisms.

Authors:  R R Scheline
Journal:  Pharmacol Rev       Date:  1973-12       Impact factor: 25.468

6.  Plasma levels and derived pharmacokinetic characteristics of unchanged nitrazepam in man.

Authors:  J Rieder
Journal:  Arzneimittelforschung       Date:  1973-02

7.  Blood level profile in man following chronic oral administration of flurazepam hydrochloride.

Authors:  S A Kaplan; J A de Silva; M L Jack; K Alexander; N Strojny; R E Weinfeld; C V Puglisi; L Weissman
Journal:  J Pharm Sci       Date:  1973-12       Impact factor: 3.534

8.  First pass conjugation and enterohepatic recycling of oxazepam in dogs; intravenous tolerance of oxazepam in propylene glycol.

Authors:  G Alván; M Jönsson; A Sundwall; J Vessman
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-01

9.  [Pharmacokinetics of bromazepam in man].

Authors:  J Raaflaub; J Speiser-Courvoisier
Journal:  Arzneimittelforschung       Date:  1974-11

10.  Triazolam disposition.

Authors:  F S Eberts; Y Philopoulos; L M Reineke; R W Vliek
Journal:  Clin Pharmacol Ther       Date:  1981-01       Impact factor: 6.875

View more
  14 in total

Review 1.  Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations.

Authors:  T Lavé; P Coassolo; B Reigner
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors:  W A Colburn; M L Jack
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

3.  Quantitative structure-activity study on human pharmacokinetic parameters of benzodiazepines using the graph theoretical approach.

Authors:  R S Markin; W J Murray; H Boxenbaum
Journal:  Pharm Res       Date:  1988-04       Impact factor: 4.200

Review 4.  The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.

Authors:  I Mahmood; J D Balian
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

5.  Prediction of the volumes of distribution of basic drugs in humans based on data from animals.

Authors:  Y Sawada; M Hanano; Y Sugiyama; H Harashima; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

6.  Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

Authors:  H Boxenbaum
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

7.  Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals.

Authors:  Y Sawada; M Hanano; Y Sugiyama; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1984-06

8.  A workflow example of PBPK modeling to support pediatric research and development: case study with lorazepam.

Authors:  A R Maharaj; J S Barrett; A N Edginton
Journal:  AAPS J       Date:  2013-01-24       Impact factor: 4.009

9.  Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.

Authors:  P H Hinderling; O Schmidlin; J K Seydel
Journal:  J Pharmacokinet Biopharm       Date:  1984-06

10.  Classification of benzodiazepine hypnotics in humans based on receptor occupancy theory.

Authors:  K Ito; Y Yamada; K Nakamura; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1993-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.